{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:13:03Z","timestamp":1791238383232,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.lfs.2014.03.025","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T14:46:59Z","timestamp":1396536419000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP)"],"prefix":"10.1016","volume":"104","author":[{"given":"Hellen Thais","family":"Fuzii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Alberto","family":"da Silva Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Jose Saraiva","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fabio Magno","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juarez Antonio Simoes","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.03.025_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biopha.2007.02.006","article-title":"Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells","volume":"61","author":"Ahuja","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.lfs.2014.03.025_bb0015","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 neurological complex","volume":"5","author":"Araujo","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0020","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/v3091532","article-title":"Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease","volume":"3","author":"Araya","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2014.03.025_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2007.09.006","article-title":"How does HTLV-I persist despite a strong cell-mediated immune response?","volume":"29","author":"Asquith","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.06.023","article-title":"Role of regulatory T cells and FOXP3 in human diseases","volume":"120","author":"Bacchetta","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I","volume":"12","author":"Bangham","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0040","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1111\/j.1365-2567.2009.03082.x","article-title":"IFN-gamma production in response to Tax 161\u2013223, and frequency of CD4+ Foxp3+ and Lin- HLA-DRhigh CD123+ cells, discriminate HAM\/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population","volume":"128","author":"Best","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2014.03.025_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2014.03.025_bb0050","doi-asserted-by":"crossref","first-page":"e8112","DOI":"10.1371\/journal.pone.0008112","article-title":"The danger is growing! A new paradigm for immune system activation and peripheral tolerance","volume":"4","author":"Bewick","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2014.03.025_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/WNL.0b013e3181b6bba9","article-title":"Neurologic abnormalities in HTLV-I and HTLV-II-infected individuals without overt myelopathy","volume":"73","author":"Biswas","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2014.03.025_bb0060","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.bjc.6605345","article-title":"Mechanisms of HTLV-1 persistence and transformation","volume":"101","author":"Boxus","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lfs.2014.03.025_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2011.08.014","article-title":"Detection of human T-cell lymphotropic virus type 1 in plasma samples","volume":"163","author":"Cabral","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.lfs.2014.03.025_bb0075","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1590\/S0004-282X2009000500016","article-title":"Pain in tropical spastic paraparesis\/HTLV-I associated myelopathy patients","volume":"67","author":"Castro-Costa","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.lfs.2014.03.025_bb0080","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1182\/blood-2007-09-113654","article-title":"Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lfs.2014.03.025_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2519\/jospt.2009.2938","article-title":"Reliability and diagnostic accuracy of clinical special tests for myelopathy in patients seen for cervical dysfunction","volume":"39","author":"Cook","year":"2009","journal-title":"J Orthop Sports Phys Ther"},{"key":"10.1016\/j.lfs.2014.03.025_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.2008.167155","article-title":"The neurology of HTLV-1 infection","volume":"9","author":"Cooper","year":"2009","journal-title":"Pract Neurol"},{"issue":"12","key":"10.1016\/j.lfs.2014.03.025_bb0095","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"Interleukin 4 inhibits TGF-\u03b2-induced-Foxp3+ T cells and generates, in combination with TGF-\u03b2, Foxp3\u2212 effector T cells that produce interleukins 9 and 10","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0100","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1099\/vir.0.79921-0","article-title":"Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells","volume":"85","author":"Dodon","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.beha.2011.09.012","article-title":"Research and discovery of the first human cancer virus, HTLV-1","volume":"24","author":"Gallo","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","article-title":"Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects","volume":"168","author":"Gessain","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.lfs.2014.03.025_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/187152808785107642","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) inflammatory network","volume":"7","author":"Goncalves","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.lfs.2014.03.025_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.lfs.2014.03.025_bb0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jmv.22087","article-title":"Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients according to new diagnostic criteria of HAM\/TSP","volume":"83","author":"Grassi","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1742-4690-6-117","article-title":"Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis","volume":"6","author":"Higuchi","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.lfs.2014.03.025_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fmicb.2012.00222","article-title":"Cellular factors involved in HTLV-1 entry and pathogenicity","volume":"3","author":"Hoshino","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3844\/ajidsp.2009.231.258","article-title":"Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review","volume":"5","author":"Irish","year":"2009","journal-title":"Am J Infect Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S0037-86822002000300008","article-title":"HTLV-I associated myelopathy in the northern region of Brazil (Bel\u00e9m-Par\u00e1): serological and clinical features of three cases","volume":"35","author":"Ishak","year":"2002","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.lfs.2014.03.025_bb0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","article-title":"Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP)","volume":"30","author":"Izumo","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.lfs.2014.03.025_bb0160","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease","volume":"186","author":"Jacobson","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0929-6646(10)60112-X","article-title":"HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30years after virus discovery","volume":"109","author":"Jeang","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.lfs.2014.03.025_bb0170","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/v3081374","article-title":"HTLV-1 and innate immunity","volume":"3","author":"Journo","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2014.03.025_bb0175","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/v2092037","article-title":"Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis","volume":"2","author":"Kannian","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2014.03.025_bb0180","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood.V77.7.1436.1436","article-title":"Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells","volume":"77","author":"Kelleher","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2014.03.025_bb0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autneu.2009.05.252","article-title":"Evaluation of autonomic malfunction in HTLV-1 associated myelopathy (HAM)","volume":"150","author":"Kuriyama","year":"2009","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.lfs.2014.03.025_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.coviro.2012.06.007","article-title":"Mechanisms of human T-lymphotropic virus type 1 transmission and disease","volume":"2","author":"Lairmore","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.lfs.2014.03.025_bb0200","doi-asserted-by":"crossref","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"Macnamara","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lfs.2014.03.025_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.patbio.2008.02.015","article-title":"The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family","volume":"57","author":"Mahieux","year":"2009","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.lfs.2014.03.025_bb0210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/v3071074","article-title":"HTLV-3\/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects","volume":"3","author":"Mahieux","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2014.03.025_bb0215","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1371\/journal.pone.0002251","article-title":"Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography","volume":"3","author":"Majorovits","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2014.03.025_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0145-2126(96)00109-9","article-title":"Frequent expression of interleukin-9 mRNA and infrequent involvement of interleukin-9 in proliferation of primary adult T-cell leukemia cells and HTLV-I infected T-cell lines","volume":"21","author":"Matsushita","year":"1997","journal-title":"Leuk Res"},{"key":"10.1016\/j.lfs.2014.03.025_bb0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","article-title":"Neuroimmunity of HTLV-I infection","volume":"5","author":"Matsuura","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/viru.19697","article-title":"Blood\u2013brain barrier and retroviral infections","volume":"3","author":"Miller","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.lfs.2014.03.025_bb0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.lfs.2014.03.025_bb0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-3083.2009.02291.x","article-title":"The elevated interferon gamma production is an important immunological marker in HAM\/TSP pathogenesis","volume":"70","author":"Montanheiro","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0255","first-page":"505","article-title":"HTLV-1 associated myelopathy\/tropical spastic paraparesis: how far have we come?","volume":"60","author":"Morgan","year":"2011","journal-title":"West Indian Med J"},{"key":"10.1016\/j.lfs.2014.03.025_bb0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/S0004-282X2006000200009","article-title":"Association of cytokines, neurological disability, and disease duration in HAM\/TSP patients","volume":"64","author":"Muniz","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.lfs.2014.03.025_bb0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13550280390194028","article-title":"Human T-cell lymphotropic virus type I and neurological diseases","volume":"9","author":"Nagai","year":"2003","journal-title":"J Neurovirol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0270","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP","volume":"50","author":"Nagai","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0275","first-page":"182","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy","volume":"47","author":"Nakamura","year":"2009","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/AJP.0b013e3181f195d3","article-title":"Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP)","volume":"27","author":"Netto","year":"2011","journal-title":"Clin J Pain"},{"key":"10.1016\/j.lfs.2014.03.025_bb0290","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/503874","article-title":"Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection","volume":"193","author":"Oh","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00281-010-0200-5","article-title":"Regulatory T cells: roles of T cell receptor for their development and function","volume":"32","author":"Ohkura","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2011.08.002","article-title":"Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis","volume":"22","author":"Oli\u00e9re","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.lfs.2014.03.025_bb0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcv.2011.02.004","article-title":"Clinical manifestations in individuals with recent diagnosis of HTLV type I infection","volume":"51","author":"Poetker","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/S0004-282X2012000400004","article-title":"HAM\/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings","volume":"70","author":"Puccioni-Sohler","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.lfs.2014.03.025_bb0320","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1590\/S0100-879X2010007500107","article-title":"In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy","volume":"43","author":"Ramirez","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.lfs.2014.03.025_bb0325","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1590\/S1020-49892010000500002","article-title":"Geographic distribution of human T-lymphotropic virus types 1 and 2 among mothers of newborns tested during neonatal screening","volume":"27","author":"Ribeiro","year":"2010","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.lfs.2014.03.025_bb0330","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S0104-42302010000300021","article-title":"Human T-cell lymphotropic virus type 1 (HTLV-1): when to suspect infection?","volume":"56","author":"Romanelli","year":"2010","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.lfs.2014.03.025_bb0335","doi-asserted-by":"crossref","first-page":"478461","DOI":"10.1155\/2010\/478461","article-title":"Immunogenetics and the pathological mechanisms of human T-cell leukemia virus type 1- (HTLV-1) associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"2010","author":"Saito","year":"2010","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1","volume":"13","author":"Santos","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.lfs.2014.03.025_bb0345","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcv.2013.05.006","article-title":"Increased osteopontin expression in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patient cells is associated with IL-17 expression","volume":"58","author":"Sarkis","year":"2013","journal-title":"J Clin Virol"},{"issue":"10","key":"10.1016\/j.lfs.2014.03.025_bb0350","doi-asserted-by":"crossref","first-page":"e2479","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.50.1","article-title":"HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases","volume":"50","author":"Satou","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.lfs.2014.03.025_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+ CD4+ T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.lfs.2014.03.025_bb0365","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1349-7006.2010.01820.x","article-title":"Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal","volume":"102","author":"Sonoda","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.lfs.2014.03.025_bb0370","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","article-title":"HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes","volume":"90","author":"Suemori","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0375","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2014.03.025_bb0380","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/319264","article-title":"Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy\/tropical spastic paraparesis than in asymptomatic carriers","volume":"183","author":"Ureta-Vidal","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lfs.2014.03.025_bb0385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF-\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2014.03.025_bb0390","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12185-011-0934-4","article-title":"Current status of HTLV-1 infection","volume":"94","author":"Watanabe","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0395","doi-asserted-by":"crossref","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","article-title":"Abnormally high levels of virus-infected INF-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder","volume":"4","author":"Yamano","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2014.03.025_bb0400","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/107327480701400206","article-title":"Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms","volume":"14","author":"Yasunaga","year":"2007","journal-title":"Cancer Control"},{"key":"10.1016\/j.lfs.2014.03.025_bb0405","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12185-011-0937-1","article-title":"Molecular mechanisms of HTLV-1 infection and pathogenesis","volume":"94","author":"Yasunaga","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.lfs.2014.03.025_bb0410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmicb.2012.00247","article-title":"HBZ and its roles in HTLV-1 oncogenesis","volume":"3","author":"Zhao","year":"2012","journal-title":"Front Microbiol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051400366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051400366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T16:38:15Z","timestamp":1716655095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051400366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":76,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S002432051400366X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.025","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}